Yawen Ju

623 total citations
21 papers, 510 citations indexed

About

Yawen Ju is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yawen Ju has authored 21 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Yawen Ju's work include Cancer Cells and Metastasis (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Lymphatic System and Diseases (3 papers). Yawen Ju is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Lymphatic System and Diseases (3 papers). Yawen Ju collaborates with scholars based in United States, China and United Kingdom. Yawen Ju's co-authors include Edward M. Schwarz, Lianping Xing, Christopher T. Ritchlin, Echoe M. Bouta, Ronald W. Wood, Jing‐Gen Liu, Zhi‐Qiang Chi, Yujun Wang, Qing Li and Minwei Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yawen Ju

21 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yawen Ju United States	12	237	205	93	93	69	21	510
Natasa Zamurovic Switzerland	9	90 0.4×	365 1.8×	66 0.7×	74 0.8×	29 0.4×	16	546
Kali Chrysovergis United States	8	119 0.5×	244 1.2×	196 2.1×	71 0.8×	32 0.5×	8	550
Mengjun Ma China	14	90 0.4×	382 1.9×	77 0.8×	75 0.8×	28 0.4×	26	595
Jumpei Teramachi Japan	17	228 1.0×	368 1.8×	67 0.7×	64 0.7×	19 0.3×	45	622
Jeffrey Chen United States	6	195 0.8×	384 1.9×	71 0.8×	39 0.4×	33 0.5×	11	712
Verónica Alonso Spain	13	201 0.8×	307 1.5×	32 0.3×	59 0.6×	28 0.4×	32	516
Robert L. Hills United States	9	97 0.4×	111 0.5×	145 1.6×	40 0.4×	22 0.3×	9	396
Semun Seong South Korea	14	123 0.5×	351 1.7×	48 0.5×	69 0.7×	11 0.2×	32	489
Lynett Danks United Kingdom	9	166 0.7×	278 1.4×	130 1.4×	352 3.8×	12 0.2×	9	710
Yasuo Yoshitomi Japan	14	152 0.6×	363 1.8×	32 0.3×	61 0.7×	23 0.3×	22	620

Countries citing papers authored by Yawen Ju

Since Specialization

Citations

This map shows the geographic impact of Yawen Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawen Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawen Ju more than expected).

Fields of papers citing papers by Yawen Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawen Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawen Ju. The network helps show where Yawen Ju may publish in the future.

Co-authorship network of co-authors of Yawen Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Yawen Ju. A scholar is included among the top collaborators of Yawen Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawen Ju. Yawen Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vaishampayan, Ulka N., Randy F. Sweis, Deepak Kilari, et al.. (2024). Phase 1 study (DRAGON) of SRK-181 (linavonkibart), a latent TGFβ1 inhibitor, combined with pembrolizumab in patients with anti-PD1 resistant advanced solid tumors: Updated results of expansion part.. Journal of Clinical Oncology. 42(16_suppl). 2507–2507. 1 indexed citations

Henry, Susan A., Stephen DeWall, Ulka N. Vaishampayan, et al.. (2023). 726 Establishing proof of mechanism in patients: preliminary biomarker data of SRK-181 (a latent TGFβ1 inhibitor) from DRAGON Study. SHILAP Revista de lepidopterología. A821–A821. 1 indexed citations

Choueiri, Toni K., Michael B. Atkins, Tracy L. Rose, et al.. (2021). A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy. Investigational New Drugs. 39(4). 1019–1027. 34 indexed citations

Yap, Timothy A., Minal Barve, Justin F. Gainor, et al.. (2021). First-in-human phase 1 trial (DRAGON) of SRK-181, a potential first-in-class selective latent TGFβ1 inhibitor, alone or in combination with anti-PD-(L)1 treatment in patients with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). TPS3146–TPS3146. 6 indexed citations

Yap, Timothy A., Minal Barve, Justin F. Gainor, et al.. (2021). 532 First-in-human phase 1 trial of SRK-181: a latent TGFβ1 inhibitor, alone or in combination with anti-PD-(L)1 treatment in patients with advanced solid tumors (DRAGON trial). Regular and Young Investigator Award Abstracts. A563–A563. 3 indexed citations

Schäfer, Claudia, Yawen Ju, Sangyoon J. Han, et al.. (2020). TRA-1-60-positive/CD45low cells found in the peripheral blood of prostate cancer patients with metastatic disease – A proof-of-concept study. Heliyon. 6(1). e03263–e03263. 3 indexed citations

Gasparetto, Cristina, Brea Lipe, Sascha A. Tuchman, et al.. (2020). Once weekly selinexor, carfilzomib, and dexamethasone (SKd) in patients with relapsed/refractory multiple myeloma (MM).. Journal of Clinical Oncology. 38(15_suppl). 8530–8530. 11 indexed citations

Heath, Elisabeth I., Lance K. Heilbrun, Daryn Smith, et al.. (2018). Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer. Anticancer Research. 38(11). 6361–6366. 17 indexed citations

Mantaj, Julia, Keith R. Fox, Khondaker Miraz Rahman, et al.. (2018). Abstract 736: Pyridinobenzodiazepines (PDDs): A new class of sequence-selective DNA mono-alkylating ADC payloads with low hydrophobicity. Cancer Research. 78(13_Supplement). 736–736. 4 indexed citations

10.

Kuzin, Igor, Stephen L. Kates, Yawen Ju, et al.. (2016). Increased numbers of CD23⁺CD21^hi Bin‐like B cells in human reactive and rheumatoid arthritis lymph nodes. European Journal of Immunology. 46(7). 1752–1757. 21 indexed citations

11.

Liang, Qianqian, Yawen Ju, Yan Chen, et al.. (2016). Lymphatic endothelial cells efferent to inflamed joints produce iNOS and inhibit lymphatic vessel contraction and drainage in TNF-induced arthritis in mice. Arthritis Research & Therapy. 18(1). 50 indexed citations

12.

Bouta, Echoe M., Jie Li, Yawen Ju, et al.. (2015). The role of the lymphatic system in inflammatory-erosive arthritis. Seminars in Cell and Developmental Biology. 38. 90–97. 49 indexed citations

13.

Bouta, Echoe M., Yawen Ju, Homaira Rahimi, et al.. (2013). Power Doppler Ultrasound Phenotyping of Expanding versus Collapsed Popliteal Lymph Nodes in Murine Inflammatory Arthritis. PLoS ONE. 8(9). e73766–e73766. 30 indexed citations

14.

Ju, Yawen, Jie Li, Chao Xie, et al.. (2013). Troponin T3 expression in skeletal and smooth muscle is required for growth and postnatal survival: Characterization of Tnnt3^{tm2a(KOMP)Wtsi} mice. genesis. 51(9). 667–675. 21 indexed citations

15.

Li, Jie, Yawen Ju, Echoe M. Bouta, et al.. (2012). Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. Arthritis & Rheumatism. 65(1). 130–138. 56 indexed citations

16.

Ju, Yawen, Homaira Rahimi, Jie Li, et al.. (2012). Validation of 3‐dimensional ultrasound versus magnetic resonance imaging quantification of popliteal lymph node volume as a biomarker of erosive inflammatory arthritis in mice. Arthritis & Rheumatism. 64(6). 2048–2050. 5 indexed citations

17.

Chiu, Yahui Grace, Kofi A. Mensah, Edward M. Schwarz, et al.. (2011). Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). Journal of Bone and Mineral Research. 27(1). 79–92. 85 indexed citations

18.

Tao, Yimin, Qinglin Li, Xuejun Xu, et al.. (2008). LPK-26, a novel κ-opioid receptor agonist with potent antinociceptive effects and low dependence potential. European Journal of Pharmacology. 584(2-3). 306–311. 41 indexed citations

19.

Salomon, J C, et al.. (2007). Rapid and Deep Control of Inflammation in Rheumatoid Arthritis with Infliximab and Its Correlation with Acute‐Phase Reactants. Annals of the New York Academy of Sciences. 1110(1). 389–401. 5 indexed citations

20.

Lin, Xin, Qing Li, Yujun Wang, et al.. (2007). Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor κB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochemical Journal. 406(2). 215–221. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact